Altair
Skip to content

Trading Analysis Report: UNH

Analysis date: 2026-10-14 · Model: gemini-4-argon · AI-generated, not financial advice.

  • Analysis date: 2026-10-14
  • Rating: Overweight
  • Generated: 2026-10-14 14:09:17
  • TradingAgents 0.6.0: google, deep gemini-4-argon, quick gemini-3.8-flash
  • Analysts: market, sentiment, news, fundamentals; research debate rounds 5, risk debate rounds 5
  • Data vendors: core_stock_apis yfinance, technical_indicators yfinance, fundamental_data sec_edgar,yfinance, news_data yfinance, macro_data fred, prediction_markets polymarket

V. Portfolio Manager Decision

Rating: Overweight

Executive Summary: We assign an Overweight rating on UNH, targeting a 1.15x to 1.25x benchmark allocation over a 3-6 month time horizon to capture its fundamental earnings turnaround without chasing the immediate post-earnings statistical stretch. Execute the build in two tranches: initiate a 30% starter tranche near current levels ($393.00-$395.62) to guarantee core participation, and deploy the remaining 70% via limit orders on a pullback into the $386.00-$388.00 support confluence (50-day SMA at $386.16 and upper Bollinger Band at $387.83). Anchor the tactical stop-loss at $371.50 (roughly 1.4x ATR below the primary accumulation zone and beneath the 20-day SMA at $375.77), while scaling out of the tactical overweight increment between $404.00-$408.00 and holding the core position toward our $438.90 valuation target.

Current Price: 395.62

Price Target: 438.9

Confidence: High

Time Horizon: 3-6 months

4. Key Risks to Monitor

  • Regulatory & Policy Scrutiny: Scrutiny over PBM transparency (OptumRx) and Medicare Advantage risk adjustment audits remains an ongoing headline risk.
  • Medical Cost Resurgence: Any unexpected seasonal uptick in inpatient hospitalizations or higher-than-anticipated medical trend would pressure insurance margins.